BNIP3L and neoplasm: Table 1 includes targets that promote mitophagy to enhance solid tumor treatment, such as BNIP3/NIX. Listed content also includes strategies to inhibit excessive mitochondrial fission (such as DRP1 inhibitor (44)) to weaken the redox homeostasis of tumor cells and increase their sensitivity to radiotherapy and chemotherapy.